Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Total 13F shares
-
67,744,971
-
Share change
-
-3,012,353
-
Total reported value
-
$1,804,059,935
-
Put/Call ratio
-
77%
-
Price per share
-
$26.63
-
Number of holders
-
170
-
Value change
-
-$97,241,940
-
Number of buys
-
81
-
Number of sells
-
104
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2021
As of 30 Jun 2021,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,744,971 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., HHLR ADVISORS, LTD., FMR LLC, STATE STREET CORP, FIRST TRUST ADVISORS LP, JPMORGAN CHASE & CO, Bank of New York Mellon Corp, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
170
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.